Skip to main content

Table 1 Outcome of infection with different doses of PRV-GD2013-ΔgI/gE and PRV-GD2013 in mice

From: Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013

Viruses

Groups

Amounts

Doses (TCID50)

Mortality (mean days to death)

LD50(TCID50)

PRV-GD2013

1

5

106.0

5/5 (3.8)

102.67

2

5

105.0

5/5 (4.0)

3

5

104.0

5/5 (4.25)

4

5

103.0

3/5 (5.0)

5

5

102.0

1/5 (5.0)

6

5

101.0

0/5

PRV-GD2013-ΔgI/gE

7

5

106.0

5/5 (5.0)

104.33

8

5

105.0

5/5 (5.8)

9

5

104.0

2/5 (6.0)

10

5

103.0

1/5 (6.0)

11

5

102.0

0/5

12

5

101.0

0/5

DMEM

13

5

0.1 ml

0/5

/